UK Head of Farm & Exports
IVC Evidensia

Paul qualified as a Veterinary Surgeon in 2000, and after an internship, joined Westpoint Farm Vets, becoming partner, owner and director along the way. In 2015, the business was sold to Private Equity, and Paul remained as Managing Director of the farm animal side of the business until 2017.

Paul then diversified away from clinical practice and set up a global leadership training and development company, Sandstone Communications, together with some other interesting people he had met along the way, from global business leaders, Olympians, Fighter pilots and elite military operators.

Paul returned to the Veterinary Sector in 2021, joining IVC Evidensia, and is currently Country Head of Farm, leading the company’s Farm Division of 300 farm vets across the UK.

Other speakers

Sven Arnouts Business Development Manager Ghent University - Provaxs
Klaus Hellmann Head of EU-CRO Argenta
Johannes Charlier Managing Director Kreavet
Nathalie Vanderheijden Coordinator fot the European Partnership on Animal Health and Welfare Ghent University
Laetitia Cicchelero Cross-Health platform coordinator - Provaxs University of Ghent
Hervé Poulet Director of Strategic Partnering Boehringer Ingelheim
Sebastiaan Theuns CEO & co-founder PathoSense
Dieter Vancraeynest External Innovation Zoetis
Beatrice Vos Partner Stonehaven Cozmix Group (SC Group)
Bryan Charleston Director and CEO The Pirbright Institute
Stewart Burgess Head of Department of Vaccines & Diagnostics Moredun Research Institute
Inne Xhonneux Project Advisor Life Sciences Flanders Innovation & Entrepreneurship (VLAIO)
Kazuhiko Hirose President and Representative Director Meiji Animal Health Co., Ltd.
Juerg Baggenstoss Partner Stonehaven Cozmix Group
Paul Dick Founder and President Paul Dick and Associates
Steve Nanchen Head External Innovation - R&D Elanco Animal Health
Erwin Blomsma CEO and Co-Founder Benno Therapeutics
Alfonso Martín-Fontecha Business Development Manager Laboratorios SYVA
Valerio Abbadessa Research Programme Officer EC DG AGRI, F2 R&I
Daisy Vanrompay Director of the Laboratory of Immunology and Animal Biotechnology Ghent University
Jennifer Serriere-Di Bartolo Biopharma Strategic Collaboration & Marketing Manager Promega
Jens Radzimanowski Director of Antibody Therapeutics Lead Identification Boehringer Ingelheim
Pieter-Jan Serreyn Technical Director AnimalhealthEurope
Charles Owen Founder and CEO 272Bio Limited
Jeremy Gowler Chief Executive Officer Ophirex, Inc.
Ivo Claassen Deputy Executive Director - Head of Veterinary Medicines Division European Medicines Agency
Jeroen Hofenk Founder & CSO SwiftPharma
Ashiqul Haque Chief scientific officer Quantoom Biosciences
Xiao Shen CEO Canton Biologics
Paweł Wielgus Member of the Management Board Bioceltix
Bert Devriendt Professor Ghent University
Endre Kiss-Tóth Founder, CEO StemcellX Limited
Edwin Veldhuizen Assistant professor Utrecht University, Faculty of Veterinary Medicine
Bing Han Lead High Tech Animal Models Wageningen Bioveterinary Research (WBVR)
Francisco LePort CEO Gordian Biotechnology
Anniek Eerdekens Postdoctoral Researcher Ghent University – WAVES/Imec
Saci Iken Business Development Manager Univercells Technologies
Thomas Robert Senior Innovation & Scientific Affairs Lead Univercells Technologies
Joni Bert Researcher Ghent University
Ulrike Diesterbeck Managing Director, Chief Scientific Officer VEROVACCiNES GmbH
Benedict Chambers CEO Prodessa Pharmceuticals
Natacha Gaillard and Ashwani Sharma Co-CEOs ASTRA Therapeutics AG
Nicolas Galmarini Co-Founder & CEO Nanogrow Biotech
Konrad Szczukiewicz Co-founder, Board Member VET CELL TECH
Ralf Herold Head of Regulatory Science and Academia, Task force Regulatory Science and Innovation, EMA European Medicines Agency
Ronaldo Avella Lavado Business Development, Operations and Regulatory Affairs Manager Paul Dick & Associates Ltd.